|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2250279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09707396.9 |
| Date of filing the European patent application | 2009-02-06 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-13 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (86) | Number | PCT/US2009/033358 |
| Date | 2009-02-06 |
| (87) | Number | WO 2009/100309 |
| Date | 2009-08-13 |
| (30) | Number | Date | Country code |
| 6962 P | 2008-02-08 | US | |
| 34618 P | 2008-03-07 | US | |
| 49970 P | 2008-05-02 | US |
| (72) |
COYLE, Anthony, US
KIENER, Peter, US
WU, Herren, US
CIBOTTI, Ricardo, US
|
| (73) |
AstraZeneca AB,
".", 151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anti-IFNAR1 antikūnai su sumažintu afiniškumu Fc ligandui |
| ANTI-IFNAR1 ANTIBODIES WITH REDUCED FC LIGAND AFFINITY |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 18 | 347.00 EUR |
| 2027-02-06 |